132 related articles for article (PubMed ID: 10579364)
1. Thyrotropin prevents apoptosis by promoting cell adhesion and cell cycle progression in FRTL-5 cells.
Li X; Lu S; Miyagi E; Katoh R; Kawaoi A
Endocrinology; 1999 Dec; 140(12):5962-70. PubMed ID: 10579364
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin interferes with thyrotropin-induced G1-S transition mediated by cAMP-dependent protein kinase and phosphatidylinositol 3-kinase. Involvement of RhoA and cyclin E x cyclin-dependent kinase 2 complexes.
Medina DL; Toro MJ; Santisteban P
J Biol Chem; 2000 May; 275(20):15549-56. PubMed ID: 10809788
[TBL] [Abstract][Full Text] [Related]
3. The phosphatase inhibitor okadaic acid stimulates the TSH-induced G1-S phase transition in thyroid cells.
Lazzereschi D; Coppa A; Minicione G; Lavitrano M; Fragomele F; Colletta G
Exp Cell Res; 1997 Aug; 234(2):425-33. PubMed ID: 9260913
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin and serum regulate thyroid cell proliferation through differential effects on p27 expression and localization.
Lewis AE; Fikaris AJ; Prendergast GV; Meinkoth JL
Mol Endocrinol; 2004 Sep; 18(9):2321-32. PubMed ID: 15166254
[TBL] [Abstract][Full Text] [Related]
5. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells.
Yamamoto K; Hirai A; Ban T; Saito J; Tahara K; Terano T; Tamura Y; Saito Y; Kitagawa M
Endocrinology; 1996 May; 137(5):2036-42. PubMed ID: 8612545
[TBL] [Abstract][Full Text] [Related]
7. Effect of ceramide on apoptosis and phospholipase D activity in FRTL-5 thyroid cells.
Park BJ; Kim JH; Han JS; Jung PM
Exp Mol Med; 1999 Sep; 31(3):142-50. PubMed ID: 10551263
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin effects on ultraviolet radiation-dependent apoptosis in FRTL-5 cells.
Del Terra E; Francesconi A; Donnini D; Curcio F; Ambesi-Impiombato FS
Thyroid; 2003 Aug; 13(8):747-53. PubMed ID: 14558917
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism responsible for thyrotropin-induced expression of microsomal/peroxidase antigen in FRTL-5 cells.
Chiovato L; Vitti P; Lombardi A; Ceccarelli P; Cucchi P; Marcocci C; Carayon P; Pinchera A
Endocrinology; 1988 Aug; 123(2):1140-6. PubMed ID: 2456200
[TBL] [Abstract][Full Text] [Related]
10. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
Paternot S; Dumont JE; Roger PP
Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
[TBL] [Abstract][Full Text] [Related]
11. Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling.
Saito J; Kohn AD; Roth RA; Noguchi Y; Tatsumo I; Hirai A; Suzuki K; Kohn LD; Saji M; Ringel MD
Thyroid; 2001 Apr; 11(4):339-51. PubMed ID: 11349832
[TBL] [Abstract][Full Text] [Related]
12. 73-kDa heat shock cognate protein interacts directly with P27Kip1, a cyclin-dependent kinase inhibitor, during G1/S transition.
Nakamura S; Tatuno I; Noguchi Y; Kitagawa M; Kohn LD; Saito Y; Hirai A
Biochem Biophys Res Commun; 1999 Apr; 257(2):340-3. PubMed ID: 10198213
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of 2-iodohexadecanal on FRTL-5 thyroid cells proliferation.
Thomasz L; Coulonval K; Salvarredi L; Oglio R; Fusco A; Rossich L; Pisarev MA; Roger PP; Juvenal GJ
Mol Cell Endocrinol; 2015 Mar; 404():123-31. PubMed ID: 25657048
[TBL] [Abstract][Full Text] [Related]
14. USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells.
Jung HS; Kim KS; Chung YJ; Chung HK; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Endocr J; 2007 Apr; 54(2):275-85. PubMed ID: 17379962
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin potentiation of insulin-like growth factor-I dependent deoxribonucleic acid synthesis in FRTL-5 cells: mediation by an autocrine amplification factor(s).
Takahashi S; Conti M; Van Wyk JJ
Endocrinology; 1990 Feb; 126(2):736-45. PubMed ID: 2404747
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of thyrotropic hormone on apoptosis induced by actinomycin D in a functioning rat thyroid cell line.
Sato H; Abe Y; Noguchi M; Kurokawa K; Sakai H
Endocr J; 1999 Apr; 46(2):309-15. PubMed ID: 10460016
[TBL] [Abstract][Full Text] [Related]
18. Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells.
Mori K; Stone S; Braverman LE; DeVito WJ
Endocrinology; 1996 Nov; 137(11):4994-9. PubMed ID: 8895373
[TBL] [Abstract][Full Text] [Related]
19. Loss of cyclin g1 expression in human uterine leiomyoma cells induces apoptosis.
Kwon SH; Park JC; Ramachandran S; Cha SD; Kwon KY; Park JK; Park JW; Bae I; Cho CH
Reprod Sci; 2008 Apr; 15(4):400-10. PubMed ID: 18497347
[TBL] [Abstract][Full Text] [Related]
20. Effects of fibroblast growth factor on type I 5'-deiodinase in FRTL-5 rat thyroid cells.
Tang KT; Braverman LE; DeVito WJ
Endocrinology; 1994 Aug; 135(2):493-500. PubMed ID: 7518381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]